{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:51Z","timestamp":1792592571606,"version":"4.5.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,22]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>In plasma, the zymogens factor XII (FXII) and prekallikrein reciprocally convert each other to the proteases FXIIa and plasma kallikrein (PKa). PKa cleaves high-molecular-weight kininogen (HK) to release bradykinin, which contributes to regulation of blood vessel tone and permeability. Plasma FXII is normally in a \u201cclosed\u201d conformation that limits activation by PKa. When FXII binds to a surface during contact activation it assumes an \u201copen\u201d conformation that increases the rate of activation by PKa. Mutations in FXII that disrupt the closed conformation have been identified in patients with conditions associated with excessive bradykinin formation. Using FXII structures from the AlphaFold database, we generated models for the closed form of human FXII that we tested with site-directed mutagenesis. The models predict multiple interactions between the fibronectin type 2 (FN2), kringle, and catalytic domains involving highly conserved amino acids that restrict access to the FXII activation cleavage sites. Based on the model, we expressed FXII with single\u2013amino acid substitutions and studied their effects on FXII activation by PKa. Replacements for Arg36 in the FN2 domain; Glu225, Asp253, or Trp268 in the kringle domain; or Lys346 near the activation cleavage site were activated &amp;gt;10-fold faster by PKa than wild-type FXII. Adding these proteins to plasma resulted in rapid HK cleavage due to markedly enhanced reciprocal activation with prekallikrein. The results support a model that explains the behavior of FXII in solution. Conformational changes involving the identified amino acids likely occur when FXII binds to a surface to facilitate activation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025015842","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:56:56Z","timestamp":1738274216000},"page":"1940-1951","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["A model of zymogen factor XII: insights into protease activation"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-1444","authenticated-orcid":false,"given":"Aleksandr","family":"Shamanaev","sequence":"first","affiliation":[{"name":"1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6533-0284","authenticated-orcid":false,"given":"Yujie","family":"Ma","sequence":"additional","affiliation":[{"name":"2Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-8004","authenticated-orcid":false,"given":"Michal B.","family":"Ponczek","sequence":"additional","affiliation":[{"name":"3Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-1409","authenticated-orcid":false,"given":"Mao-fu","family":"Sun","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quifang","family":"Cheng","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Kent","family":"Dickeson","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9481-0124","authenticated-orcid":false,"given":"Owen J. T.","family":"McCarty","sequence":"additional","affiliation":[{"name":"4Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-8030","authenticated-orcid":false,"given":"Jonas","family":"Emsley","sequence":"additional","affiliation":[{"name":"2Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-3663","authenticated-orcid":false,"given":"Bassem M.","family":"Mohammed","sequence":"additional","affiliation":[{"name":"5Department of Biochemistry and Molecular Biology, Edward A. Doisy Research Center, St. Louis University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-8014","authenticated-orcid":false,"given":"David","family":"Gailani","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"8","key":"2025042208464416100_bib1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jth.13383","article-title":"FXII: form determines function","volume":"14","author":"de Maat","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"17","key":"2025042208464416100_bib2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"issue":"7","key":"2025042208464416100_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0043-1769509","article-title":"Factor XII structure-function relationships","volume":"50","author":"Shamanaev","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2025042208464416100_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2025042208464416100_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: an interface between inflammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2025042208464416100_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/0929867328666210804085636","article-title":"C1-inhibitor: structure, functional diversity and therapeutic development","volume":"29","author":"Karnaukhova","year":"2022","journal-title":"Curr Med Chem"},{"issue":"9","key":"2025042208464416100_bib7","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/jth.14209","article-title":"Hereditary angioedema: the plasma contact system out of control","volume":"16","author":"De Maat","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2025042208464416100_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI125378","article-title":"The hereditary angioedema syndromes","volume":"129","author":"Schmaier","year":"2019","journal-title":"J\u00a0Clin Investig"},{"issue":"7","key":"2025042208464416100_bib9","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1055\/s-0042-1758820","article-title":"Hereditary angioedema: the clinical picture of excessive contact activation","volume":"50","author":"Petersen","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"20","key":"2025042208464416100_bib10","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.2018.16773","article-title":"Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial","volume":"320","author":"Banerji","year":"2018","journal-title":"JAMA"},{"issue":"10382","key":"2025042208464416100_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(23)00350-1","article-title":"Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Craig","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"2025042208464416100_bib12","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/bloodadvances.2021005976","article-title":"Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains","volume":"6","author":"Shamanaev","year":"2022","journal-title":"Blood Adv"},{"key":"2025042208464416100_bib13","doi-asserted-by":"crossref","first-page":"1146834","DOI":"10.3389\/fphys.2023.1146834","article-title":"Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity","volume":"14","author":"Shamanaev","year":"2023","journal-title":"Front Physiol"},{"issue":"4","key":"2025042208464416100_bib14","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2025042208464416100_bib15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2016.02.021","article-title":"Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations","volume":"138","author":"de Maat","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"2025042208464416100_bib16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2018-06-860270","article-title":"A\u00a0mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain","volume":"133","author":"Ivanov","year":"2019","journal-title":"Blood"},{"issue":"5","key":"2025042208464416100_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOH.0000000000000727","article-title":"Recent advances in factor XII structure and function","volume":"29","author":"Shamanaev","year":"2022","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"2025042208464416100_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0039-3402760","article-title":"The fibronectin type II domain of factor XII ensures zymogen quiescence","volume":"120","author":"Clark","year":"2020","journal-title":"Thromb Haemost"},{"issue":"7873","key":"2025042208464416100_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"2025042208464416100_bib20","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2025042208464416100_bib21","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.04.463034","article-title":"Protein complex prediction with AlphaFold-multimer","author":"Evans","year":"10  2022","journal-title":"bioRxiv"},{"issue":"8016","key":"2025042208464416100_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"11","key":"2025042208464416100_bib23","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci"},{"issue":"D1","key":"2025042208464416100_bib24","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"UniProt Consortium","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025042208464416100_bib25","unstructured":"National Center for Biotechnology Information\n          . Coagulation factor XII [Homo sapiens (human)]. Accessed 28 December 2023. https:\/\/www.ncbi.nlm.nih.gov\/gene\/2161#:\u223c:text=Factor%20XII%20impairs%20arterial%20thrombus,but%20not%20in%20normal%20hemostasis."},{"issue":"5","key":"2025042208464416100_bib26","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtha.2022.12.014","article-title":"Titanium is a potent inducer of contact activation: implications for intravascular devices","volume":"21","author":"Litvak","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2025042208464416100_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jtha.2023.09.027","article-title":"High-molecular-weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation","volume":"22","author":"Mohammed","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2025042208464416100_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood.2019002224","article-title":"Protease activity in single-chain prekallikrein","volume":"135","author":"Ivanov","year":"2020","journal-title":"Blood"},{"issue":"11","key":"2025042208464416100_bib29","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2016-10-744110","article-title":"Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation","volume":"129","author":"Ivanov","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2025042208464416100_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/a-1951-1777","article-title":"Factor XII explored with AlphaFold \u2013 opportunities for selective drug development","volume":"123","author":"Frunt","year":"2023","journal-title":"Thromb Haemost"},{"issue":"6","key":"2025042208464416100_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jtha.2023.02.014","article-title":"A\u00a0site on factor XII required for productive interactions with polyphosphate","volume":"21","author":"Shamanaev","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"2025042208464416100_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fmed.2018.00066","article-title":"Cell receptor and cofactor interactions of the contact activation system and factor XI","volume":"5","author":"Pathak","year":"2018","journal-title":"Front Med"},{"issue":"11","key":"2025042208464416100_bib32","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1182\/blood.V86.11.4134.bloodjournal86114134","article-title":"Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein","volume":"86","author":"Ravon","year":"1995","journal-title":"Blood"},{"issue":"2","key":"2025042208464416100_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12195-020-00657-6","article-title":"Development of coagulation factor XII antibodies for inhibiting vascular device-related thrombosis","volume":"14","author":"Kohs","year":"2021","journal-title":"Cell Mol Bioeng"},{"issue":"6","key":"2025042208464416100_bib34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1160\/TH06-03-0128","article-title":"Plasma levels of bradykinin are suppressed in factor XII-deficient mice","volume":"95","author":"Iwaki","year":"2006","journal-title":"Thromb Haemost"},{"issue":"19","key":"2025042208464416100_bib35","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1182\/blood-2011-05-355248","article-title":"Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding","volume":"118","author":"Revenko","year":"2011","journal-title":"Blood"},{"issue":"14","key":"2025042208464416100_bib37","first-page":"1685","article-title":"Factor XII and kininogen asymmetric assembly with gC1qR\/C1QBP\/P32 is governed by allostery","volume":"136","author":"Kaira","year":"2020","journal-title":"Blood"},{"issue":"suppl 1","key":"2025042208464416100_bib38","first-page":"29","article-title":"Factor XII heavy chain structure [abstract] Oral Communication abstracts","volume":"6","author":"Emsley","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"2025042208464416100_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.celrep.2012.02.012","article-title":"The X-ray crystal structure of full-length human plasminogen","volume":"1","author":"Law","year":"2012","journal-title":"Cell Rep"},{"issue":"1","key":"2025042208464416100_bib40","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1038\/s41598-018-21304-1","article-title":"Structure of prothrombin in the closed form reveals new details on the mechanism of activation","volume":"8","author":"Chinnaraj","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"2025042208464416100_bib41","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood.V97.8.2342","article-title":"Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells","volume":"97","author":"Mahdi","year":"2001","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/8\/1940\/2369334\/blooda_adv-2025-015842-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/8\/1940\/2369334\/blooda_adv-2025-015842-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:46:54Z","timestamp":1745326014000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/8\/1940\/535372\/A-model-of-zymogen-factor-XII-insights-into"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,4,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025015842","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]}}}